SOPHARMA AD: Treasury shares

2023-12-12 14:59

publikacja
2023-12-12 14:59

Spis treści:

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
Current_report_220_buy_back_espi.pdf (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
		UNI - EN REPORT No		220	/	2023
Date of issue:	2023-12-12
Short name of the issuer
SOPHARMA AD
Subject
Treasury shares
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on December 11, 2023 the Company bought 150 000 (one hundred and fifty thousand) own shares representing 0.087% of the share capital of the Company, at a total value of BGN 915,000 on the Bulgarian Stock Exchange, the average price per share was BGN 6.10. The total number of treasury shares after this transaction is 13,894,336 representing 8.05% of the share capital of the Company.
Annexes
File			Description
Current report_220_buy back_espi.pdfCurrent report_220_buy back_espi.pdf			Treasury shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date	Name	Position / Function	Signature
2023-12-12	Ognian Donev	Executive Director

Ważne linki